Sickle cell disease: The past, present and future social and ethical dilemmas

Renaissance of Sickle Cell Disease Research in the Genome Era

Volumn , Issue , 2007, Pages 311-323

  Bonham, Vence L ^a   Haywood, Carlton ^b   Gamble, Vanessa Northington ^c  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b Tuskegee University National Center for Bioethics in Research and Health Care ^*

^c TUSKEGEE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79961136703     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9781860947964_0019     Document Type: Chapter

References (58)

1. Atkin K, Ahmad WI (1998). Genetic screening and haemoglobinopathies: ethics, politics and practice. Soc Sci Med 46(3):445-458.
2. Wailoo K (2001). Dying in the City of the Blues: Sickle Cell Anemia and the Politics of Race And Health. Chapel Hill and London: The University of North Carolina Press.
3. Tapper M (1999). In the Blood: Sickle Cell Anemia and the Politics of Race. Philadelphia: University of Pennsylvania Press.
4. Savitt TL, Goldberg MF (1989). Herrick’s 1910 case report of sickle cell anemia. The rest of the story. JAMA 261(2):266-271.
5. Gamble VN (1999). Race and the new genetics: a historical perspective. In: Hager M, editor. The Implications of Genetics for Health Professionals. Josiah Macy Foundation.
6. Herrick JB (1910). Peculiar elongated and sickle-shaped red corpuscles in a case of severe anemia. Arch Intern Med 6:517-521.
7. Mason VR (1985). Landmark article Oct. 14, 1922: sickle cell anemia. By V. R. Mason. JAMA 254(14): 1955-1957.
8. Editorial (1997). Sickle cell anemia: a race specific disease. JAMA 133:33-34.
9. Wailoo K (1996). Genetic marker of segregation: sickle cell anemia, thalassemia, and racial ideology in American medical writing 1920-1950. Hist Philos Life Sci 18(3):305-320.
10. Ogden MA (1943). Sickle cell anemia in the white race. Arch Intern Med 71:169-182.
11. Cooley TB, Lee P (1929). Sickle cell anemia in a Greek family. Am J Dis Child 38:105-106.
12. Graham GS, McCarty SH (1930). Sickle cell (Meniscocytic) anemia. South Med J 23(7):600.
13. Scott RB (1970). Health care priority and sickle cell anemia. JAMA 214(4):731-734.
14. Nixon RM (1971). National Health Strategy. The President’s Message to the Congress Proposing a Comprehensive Health Policy for the Seventies. Weekly Compilation of Presidential Documents 7, 254.
15. Rutkow IM, Lipton JM (1974). Some negative aspects of sickle cell anemia screening programs (negative aspects of sickle cell screening). Conn Med 38(5):257-262.
16. Bowman JE (1960). Genetic screening programs and public policy. Phylon 38(2):117-142.
17. Collins FS, Green ED, Guttmacher AE, Guyer MS (2003). A vision for the future of genomics research. Nature 422(6934):835-847.
18. Higginbotham EB (1992). African-American womens history and the metalanguage of race. Signs 17(2):251-274.
19. Bonham VL, Warshauer-Baker E, Collins FS (2005). Race and ethnicity in the genome era: the complexity of the constructs. Am Psychol 60(1):9-15.
20. Cooper RS, Kaufman JS, Ward R (2003). Race and genomics. N Engl J Med 348(12):1166-1170.
21. Schwartz RS (2001). Racial profiling in medical research. N Engl J Med 344(18):1392-1393.
22. Duster T (2005). Medicine. Race and reification in science. Science 307(5712):1050-1051.
23. Burchard EG, Ziv E, Coyle N, Gomez SL, Tang H, Karter AJ, Mountain JL, Perez-Stable EJ, Sheppard D, Risch N (2003). The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 348(12):1170-1175.
24. Risch N, Burchard E, Ziv E, Tang H (2002). Categorization of humans in biomedical research: genes, race and disease. Genome Biol 3(7):1-12.
25. Bamshad M (2005). Genetic influences on health: does race matter? JAMA 294(8):937-946.
26. Collins FS (2004). What we do and don’t know about ‘race’, ‘ethnicity’, genetics and health at the dawn of the genome era. Nat Genet 36(11 Suppl):13-15.
27. Feldman MW, Lewontin RC, King MC (2003). Race: a genetic melting-pot. Nature 424(6947):374.
28. Rotimi CN (2004). Are medical and non-medical uses of large-scale genomic markers conflating genetics and ‘race’? Nat Genet 36(11 Suppl):S43-S47.
29. Condit CM, Parrott R, Harris TM (2002). Lay understandings of the relationship between race and genetics: development of a collectivized knowledge through shared discourse. Public Underst Sci 11:373-387.
30. Guttmacher AE, Collins FS, Carmona RH (2004). The family history-more important than ever. N Engl J Med 351(22):2333-2336.
31. Rich EC, Burke W, Heaton CJ, Haga S, Pinsky L, Short MP, Acheson L (2004). Reconsidering the family history in primary care. J Gen Intern Med 19(3):273-280.
32. Rushton JP, Jensen AR (2005). Thirty years of research on race differences in cognitive ability. Psychol Public Policy Law 11(2):235-294.
33. King PA (1992). The dangers of difference. Hastings Cent Rep 22:35-38.
34. National Human Genome Research Institute Website. Available: http://www.genome.gov/10001754. Accessed September 21, 2005.
35. National Human Genome Research Institute Website. Available: http://www.genome.gov/10001796. Accessed September 21, 2005.
36. National Institutes of Health. Notice HG-05-002 Release, February 4, 2005, Issued by the National Human Genome Research Institute.
37. National Human Genome Research Institute Website. New Directions for Sickle Cell Therapy in the Genome Era, Conference Summary. Available: http://www.genome.gov/11509561.
38. Boulware LE, Cooper LA, Ratner LE, LaVeist TA, Powe NR (2003). Race and trust in the health care system. Public Health Rep 118(4):358-365.
39. Voils CI, Oddone EZ, Weinfurt KP, Friedman JY, Schulman KA, Bosworth HB (2005). Whotrusts healthcare institutions? Results from a community-based sample. Ethn Dis 15(1):97-103.
40. Dula A (1994). African-American suspicion of the healthcare system is justified: what do we do about it? Camb Q Healthc Ethics 3(3):347-357.
41. Goold SD (2001). Trust and the ethics of health care institutions. Hastings Cent Rep 31(6):26-33.
42. Crawley LM (2001). African-American participation in clinical trials: situating trust and trustworthiness. J Natl Med Assoc 93(12 Suppl):14S-17S.
43. Hall MA, Dugan E, Zheng B, Mishra AK (2001). Trust in physicians and medical institutions: what is it, can it be measured, and does it matter? Milbank Q 79(4):613-639.
44. Beauchamp TL, Childress JF (2001). Principles of Biomedical Ethics, 5th edition. New York: Oxford University Press.
45. Gamble VN (1997). Under the shadowof Tuskegee: African-Americans and health care. Am J Public Health 87(11):1773-1778.
46. Corbie-Smith G, Thomas SB, St George DM (2002). Distrust, race, and research. Arch Intern Med 162(21):2458-2463.
47. Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S (1999). Attitudes and beliefs of African-Americans toward participation in medical research. J Gen Intern Med 14(9):537-546.
48. Freimuth VS, Quinn SC, Thomas SB, Cole G, Zook E, Duncan T (2001). African-Americans’ views on research and the Tuskegee Syphilis Study. Soc Sci Med 52(5):797-808.
49. Shavers VL, Lynch CF, Burmeister LF (2002). Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol 12(4):248-256.
50. Furr LA (2002). Perceptions of genetics research as harmful to society: differences among samples of African-Americans and European-Americans. Genet Test 6(1):25-30.
51. Schulz A, Caldwell C, Foster S (2003). “What are they going to do with the information?” Latino/Latina and African-American perspectives on the Human Genome Project. Health Educ Behav 30(2):151-169.
52. Mittman IS, Secundy MG (1998). A national dialogue on genetics and minority issues. Community Genet 1(3):190-200.
53. Charache S, Terrin ML, Moore RD, Dover GJ, McMahon RP, Barton FB, Waclawiw M, Eckert SV (1995). Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea. Control Clin Trials 16(6):432-446.
54. Gaston M, Smith J, Gallagher D, Flournoy-Gill Z, West S, Bellevue R, Farber M, Grover R, Koshy M, Ritchey AK et al. (1987). Recruitment in the Cooperative Study of Sickle Cell Disease (CSSCD). Control Clin Trials 8(4 Suppl):131S-140S.
55. Jones FC, Broome ME (2001). Focus groups with African-American adolescents: enhancing recruitment and retention in intervention studies. J Pediatr Nurs 16(2):88-96.
56. Nield-Anderson L, Dixon JK, Lee K (1999). Random assignment and patient choice in a study of alternative pain relief for sickle cell disease. West J Nurs Res 21(2):266-274.
57. Olujohungbe A, Cinkotai KI, Yardumian A (1998). Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising results. Br Med J 316(7146):1689.
58. Cooper LA, Roter DL, Johnson RL, Ford DE, Steinwachs DM, Powe NR (2003). Patient-centered communication, ratings of care, and concordance of patient and physician race. Ann Intern Med 139(11):907-915.